ICUI - ICU Medical Inc

ICUI - ICU Medical Inc

https://www.icumed.com

Buy Momentum: Bearish

Recent News

Powered by Alpha Vantage

FDA Identifies ICU Medical's Plum Duo Recall as Serious Type

Zacks Commentary • 2 weeks ago • score: -0.09

ICUI faces an FDA recall of its Plum Duo Infusion System over software flaws, though devices remain in use, pending fixes.

ICU Medical to Participate in Upcoming Investor Conferences

GlobeNewswire • 3 weeks, 4 days ago • score: 0.47

SAN CLEMENTE, Calif., Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- ICU Medical ( Nasdaq:ICUI ) , a leader in the development, manufacture and sale of innovative medical products, today announced its participation in the following investor conferences in September: ...

This Parker-Hannifin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Exodus Movement ( AMEX:EXOD ) , ICU Medical ( NASDAQ:ICUI )

Benzinga • 1 month ago • score: -0.02

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Wells Fargo initiated coverage on Revolution Medicines, Inc.

ICU Medical ( ICUI ) Surpasses Q2 Earnings and Revenue Estimates

Zacks Commentary • 1 month, 1 week ago • score: 0.15

ICU Medical (ICUI) delivered earnings and revenue surprises of +45.83% and +0.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

ICU Medical Announces Time of Second Quarter 2025 Earnings Conference Call

GlobeNewswire • 1 month, 3 weeks ago • score: 0.52

SAN CLEMENTE, Calif., July 24, 2025 ( GLOBE NEWSWIRE ) -- ICU Medical, Inc. ( Nasdaq: ICUI ) , a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2025 earnings release and conference call.

ICU Medical ( ICUI ) Q1 Earnings and Revenues Beat Estimates

Zacks Commentary • 4 months ago • score: 0.07

ICU Medical (ICUI) delivered earnings and revenue surprises of 39.84% and 5.54%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

ICU Medical, Inc. develops, manufactures and sells medical devices used in infusion therapy and critical care applications worldwide. The company is headquartered in San Clemente, California.

52W High

$196.26

52W Low

$107.00

MA Status:

50D: Above 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.87

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

15.62

EV/EBITDA (<8 favorable)

13.42

EV/Revenue (<3 favorable)

1.83

P/S (TTM) (<3 favorable)

1.37

P/B (<3 favorable)

1.53

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

3.14%

Institutions (25–75% balanced)

113.38%

Shares Outstanding

24,685,700

Float

23,900,700

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

2,372,504,000

Gross Profit (TTM)

850,283,000

EPS (TTM)

-1.52

Profit Margin (>10% good)

-0.02%

Operating Margin (TTM) (higher better)

0.05%

ROE (TTM) (>15% strong)

-0.02%

EPS YoY (Quarterly) (>10% good)

-0.24

Revenue YoY (Quarterly) (>8% good)

-0.08

Momentum

Bearish momentum

Value

2.6203

Previous

2.7792

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025